Literature DB >> 20403473

Apoptosis as a mechanism for the elimination of cardiomyocytes after acute myocardial infarction.

Marek Prech1, Andrzej Marszałek, Josef Schröder, Violetta Filas, Maciej Lesiak, Marek Jemielity, Aleksander Araszkiewicz, Stefan Grajek.   

Abstract

Apoptosis is recognized as a mechanism of cell loss in the setting of acute myocardial infarction (AMI). Whether it contributes to myocyte elimination late after AMI has not yet been confirmed. We attempted to identify the features of apoptosis in myocytes that survived AMI. A search for ongoing apoptosis was performed in samples obtained from 38 human hearts: group I (n = 10), noncardiac death (control); and group II (n = 28), left ventricular aneurysm (in 20 patients, the samples were collected during aneurysmectomy and from 8 at autopsy). The morphometric evaluation included the degree of cellular hypertrophy, density of the capillary network, extent of myocytolysis, and features of apoptosis. Immunohistochemistry for caspase-3 and Bcl-2 was used as a prerequisite for transmission electron microscopy. Slides showing the strongest reaction for caspase-3 and negative for Bcl-2 were selected for transmission electron microscopy. CD-34 immunohistochemistry was used to quantify the capillary density. A significant reduction in capillary density was observed compared to the control group (1,085.6 + or - 205.0/mm(2) vs 2,968.7 + or - 457.3/mm(2); p <0.001). Myocytes that survived the acute phase of AMI were significantly hypertrophied (24.5 + or - 4.7 microm vs 14.5 + or - 1.6 microm; p <0.001) and showed a moderate to severe degree of myocytolysis. The average intensity score of the immunohistochemistry reactions for caspase-3 was 8.2 + or - 3.8. Using transmission electron microscopy, apoptotic bodies were found in caspase-3-positive samples. In conclusion, the expression of caspase-3 and the presence of apoptotic bodies confirmed apoptosis as a common pathway of cardiomyocyte death in the setting of a limited blood supply after AMI. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20403473     DOI: 10.1016/j.amjcard.2009.12.039

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  20 in total

Review 1.  Anti-apoptosis in nonmyocytes and pro-autophagy in cardiomyocytes: two strategies against postinfarction heart failure through regulation of cell death/degeneration.

Authors:  Genzou Takemura; Hiromitsu Kanamori; Hideshi Okada; Nagisa Miyazaki; Takatomo Watanabe; Akiko Tsujimoto; Kazuko Goto; Rumi Maruyama; Takako Fujiwara; Hisayoshi Fujiwara
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

2.  Autophagy inhibitor 3-methyladenine alleviates overload-exercise-induced cardiac injury in rats.

Authors:  Hua Liu; Hui Lei; Yue Shi; Jin-Ju Wang; Ning Chen; Zhang-Hua Li; Yan-Fang Chen; Qi-Fa Ye; Yi Yang
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

Review 3.  Striking a balance: autophagy, apoptosis, and necrosis in a normal and failing heart.

Authors:  Wajihah Mughal; Rimpy Dhingra; Lorrie A Kirshenbaum
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

4.  A kinase interacting protein (AKIP1) is a key regulator of cardiac stress.

Authors:  Mira Sastri; Kristofer J Haushalter; Mathivadhani Panneerselvam; Philip Chang; Heidi Fridolfsson; J Cameron Finley; Daniel Ng; Jan M Schilling; Atsushi Miyanohara; Michele E Day; Hiro Hakozaki; Susanna Petrosyan; Antonius Koller; Charles C King; Manjula Darshi; Donald K Blumenthal; Sameh Saad Ali; David M Roth; Hemal H Patel; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

5.  Sparstolonin B attenuates hypoxia-induced apoptosis, necrosis and inflammation in cultured rat left ventricular tissue slices.

Authors:  Qing Liu; Jianping Li; Shaiban Jubair; Dawei Wang; Yi Luo; Daping Fan; Joseph S Janicki
Journal:  Cardiovasc Drugs Ther       Date:  2014-10       Impact factor: 3.727

6.  Synthesis and evaluation of an anti-MLC1 × anti-CD90 bispecific antibody for targeting and retaining bone-marrow-derived multipotent stromal cells in infarcted myocardium.

Authors:  C William Gundlach; Amy Caivano; Maria da Graca Cabreira-Hansen; Amir Gahremanpour; Wells S Brown; Yi Zheng; Bradley W McIntyre; James T Willerson; Richard A F Dixon; Emerson C Perin; Darren G Woodside
Journal:  Bioconjug Chem       Date:  2011-08-02       Impact factor: 4.774

7.  Cell death signalling mechanisms in heart failure.

Authors:  Wajihah Mughal; Lorrie A Kirshenbaum
Journal:  Exp Clin Cardiol       Date:  2011

8.  LncRNA TUG1 aggravates cardiomyocyte apoptosis and myocardial ischemia/reperfusion injury.

Authors:  Dongliang Fu; Tong Gao; Mengru Liu; Chunyan Li; Haiwei Li; Hong Jiang; Xianlun Fu
Journal:  Histol Histopathol       Date:  2021-10-20       Impact factor: 2.303

9.  Baicalin ameliorates isoproterenol-induced acute myocardial infarction through iNOS, inflammation, oxidative stress and P38MAPK pathway in rat.

Authors:  Shen-Jie Sun; Xiao-Peng Wu; Heng-Liang Song; Gui-Qi Li
Journal:  Int J Clin Exp Med       Date:  2015-12-15

10.  Enhanced sensitivity to low dose irradiation of ApoE-/- mice mediated by early pro-inflammatory profile and delayed activation of the TGFβ1 cascade involved in fibrogenesis.

Authors:  Virginie Monceau; Lydia Meziani; Carine Strup-Perrot; Eric Morel; Magret Schmidt; Julia Haagen; Brigitte Escoubet; Wolfgang Dörr; Marie-Catherine Vozenin
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.